Revenio Group Oyj — Director's Dealing 2022

May 23, 2022

REVENIO

Revenio Group Corporation: Managers' Transactions - Ari Isomäki

Revenio Group Corporation Managers' transactions May 23, 2022 at 9.30 a.m. (EEST)

Revenio Group Oyj: Managers' Transactions - Ari Isomäki

Person subject to the notification requirement

Name: Ari Isomäki

Position: Other senior manager

Issuer: Revenio Group Oyj

LEI: 743700127E0FWSXLKK04

Notification type: INITIAL NOTIFICATION

Reference number: 15343/7/6

Transaction date: 2022-05-19

Venue: NASDAQ HELSINKI LTD (XHEL)

Instrument type: SHARE

ISIN: F10009010912

Nature of the transaction: DISPOSAL

Transaction details

(1): Volume: 500 Unit price: 45 EUR

Aggregated transactions

(1): Volume: 500 Volume weighted average price: 45 EUR

For further information, please contact:

CFO Robin Pulkkinen, tel. +358 50 505 9932

robin.pulkkinen@revenio.fi

www.revenio.fi

DISTRIBUTION:

Nasdaq Helsinki Ltd

Main media

www.revenio.fi

Revenio Group in brief

Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio's ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand. iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for the diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD). iCare software solutions provide eye care professionals with new innovative digital clinical tools that drive greater efficiency and enhance the quality of care.

Revenio Group

Äyritie 22

FI-01510 Vantaa

---

REVENIO

In 2021, the Group's net sales totaled EUR 78.8 million, with an operating profit of EUR 22.1 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Attachments

Revenio Group Corporation: Managers' Transactions – Ari Isomäki

Revenio Group | Äyritie 22 | FI-01510 Vantaa